Helminth infections: the great neglected tropical diseases
Top Cited Papers
Open Access
- 1 April 2008
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 118 (4) , 1311-1321
- https://doi.org/10.1172/jci34261
Abstract
Helminths are parasitic worms. They are the most common infectious agents of humans in developing countries and produce a global burden of disease that exceeds better-known conditions, including malaria and tuberculosis. As we discuss here, new insights into fundamental helminth biology are accumulating through newly completed genome projects and the nascent application of transgenesis and RNA interference technologies. At the same time, our understanding of the dynamics of the transmission of helminths and the mechanisms of the Th2-type immune responses that are induced by infection with these parasitic worms has increased markedly. Ultimately, these advances in molecular and medical helminth biology should one day translate into a new and robust pipeline of drugs, diagnostics, and vaccines for targeting parasitic worms that infect humans.Keywords
This publication has 162 references indexed in Scilit:
- Alternatively activated macrophages in helminth infectionsCurrent Opinion in Immunology, 2007
- IL-31–IL-31R interactions negatively regulate type 2 inflammation in the lungThe Journal of Experimental Medicine, 2007
- Evaluation of the In Vivo Activity of Tribendimidine against Schistosoma mansoni , Fasciola hepatica , Clonorchis sinensis , and Opisthorchis viverriniAntimicrobial Agents and Chemotherapy, 2007
- Spatial epidemiology of human schistosomiasis in Africa: risk models, transmission dynamics and controlTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasitesNature Medicine, 2006
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune systemThe Journal of Experimental Medicine, 2006
- Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsionThe Journal of Experimental Medicine, 2006
- Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tractThe Journal of Experimental Medicine, 2006
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and MalariaPLoS Medicine, 2006